LONDON and RALEIGH, N.C., June 27, 2023 (GLOBE NEWSWIRE) Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma” or the “Company”) announces the submission of a New Drug Application (“NDA”) to the US Food and Drug Admin.
Verona Pharma to Present at Jefferies Healthcare Conference streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
LONDON and RALEIGH, N.C., April 25, 2023 Verona Pharma plc , a clinical-stage biopharmaceutical company focused on respiratory diseases, announces that it will report its financial results for. | April 25, 2023
21.02.2023 - LONDON and RALEIGH, N.C., Feb. 21, 2023 (GLOBE NEWSWIRE) - Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma” or the “Company”), a clinical-stage biopharmaceutical company focused on respiratory diseases, announces that it will report its financial .